A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Aura Biosciences
Aura Biosciences
EvolveImmune United, Inc
Seagen Inc.
Pfizer
Pfizer
IDEAYA Biosciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Beijing Biotech
Eli Lilly and Company
Eli Lilly and Company
University of California, Davis
University of California, Davis
BeOne Medicines
ViroMissile, Inc.
Tizona Therapeutics, Inc
Pilatus Biosciences Inc
Clasp Therapeutics, Inc.
Baylor College of Medicine
MacroGenics
Tongji Hospital
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
OncoNano Medicine, Inc.
Jonsson Comprehensive Cancer Center
Daiichi Sankyo
Totus Medicines
Monopar Therapeutics
Monopar Therapeutics
Abramson Cancer Center at Penn Medicine
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Fudan University